Efficacy and safety of paclitaxel/ramucirumab as the second-line chemotherapy in Japanese patients with advanced gastric cancer.

Tetsuya Kusumoto,Akinori Egashira,Hideto Sonoda,Kenkichi Hashimoto,Hideo Uehara,Eiji Kusumoto,Chiaki Shinzato,Keita Uchino,Yoshihisa Sakaguchi,Koji Ikejiri,Yoshihiko Maehara

Efficacy and safety of paclitaxel/ramucirumab as the second-line chemotherapy in Japanese patients with advanced gastric cancer.

2017

Tetsuya Kusumoto
Akinori Egashira
Hideto Sonoda
Kenkichi Hashimoto
Hideo Uehara
Eiji Kusumoto
Chiaki Shinzato
Keita Uchino
Yoshihisa Sakaguchi
Koji Ikejiri
Yoshihiko Maehara

e15540Background: Second-line chemotherapy can now be considered as a proven treatment option for metastatic or locally advanced gastric cancer (AGC). Two global randomized phase III trials (REGARD...

Keywords:

Ramucirumab
Cancer
Physical therapy
Paclitaxel
Cancer research
Chemotherapy
Medicine
Oncology
Internal medicine
locally advanced
second line chemotherapy
treatment options
advanced gastric cancer
Pathology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations